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Salmophage®: a new preparation for treatment and
immune prevention of salmonellosis in fowls
Salmophage® : une nouvelle préparation pour 
le traitement et la prévention vaccinale de la
salmonellose chez les volailles
Par A.N. PANIN(1), S.V. LENYOV(1), Y.A. MALAKHOV(1) et E.A. SVETOCH(2)
(communication présentée le 9 juin 2005, par Alain PHILIPPON)
Salmophage® est une nouvelle préparation développée contre la salmonellose du poulet, et consti-
tuée d’un vaccin sec vivant et d’un bactériophage. Au contraire des vaccins conventionnels qui indui-
sent uniquement une immunité active contre la souche vaccinale, Salmophage® a aussi un effet thé-
rapeutique grâce au phage qu’il contient.
L’inoculation expérimentale à des souris blanches et des poulets a démontré que Salmophage® est
plus efficace comme agent de prévention que les vaccins traditionnels, particulièrement lorsque la
contamination a lieu à des périodes où les animaux ne sont pas capables de développer une immu-
nité active. Ainsi, la composante « phage » peut prévenir la mort de poussins fortement contaminés
dans leurs premiers jours de vie.
Une étude préliminaire chez des poulets d’élevage infectés avec Salmonella montre que Salmophage®
augmente leur survie et permet d’obtenir des produits indemnes de Salmonella enteritidis.
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RÉSUMÉ
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Salmophage® is a new preparation developed against salmonellosis in fowl. It has two components:
a dry live vaccine and a bacteriophage. Unlike conventional vaccines which trigger solely an active
immune response against the vaccine strain, Salmophage® also has a therapeutic effect due to its phage
component.
Experimental inoculation in white mice and chicken demonstrated that Salmophage® is more effective
as a preventive agent that the conventional vaccine, especially when Salmonella contamination occurs
at a time when animals are unable to develop an active immunity. Therefore, the phage component of
the preparation can prevent the death of chicks heavily contaminated just a few days after hatching.
A preliminary investigation in Salmonella-infected chicken showed that Salmophage® improves animal
survival and helps produce poultry products free of Salmonella enteritidis.
Key words: vaccine, chicken, Salmonella, bacteriophage.
SUMMARY
• INTRODUCTION
Salmonellosis belongs to zoonoses which are widespread
in Russia and in many other countries and has no equals
among other zoonoses in the abundance of serovars of cau-
sative agent and difficulties arising in the process of their
control. In the past 15-20 years the pride of place has been
taken by serovar S. enterica ser. Enteritidis which causes toxi-
infections in humans. Wild and domestic fowl, poultry in par-
ticular, constitute a major reservoir of these micro-organisms
in nature. Along with its big social importance, salmonellosis
causes serious economic damage to poultry farming.
Furthermore according to veterinary statistical returns in Rus-
sia, salmonellosis is responsible for the death of more than
one-third of all fallen chickens.
Methods employed to control salmonellosis in industrial
poultry farming are reduced to implementing organizational,
veterinary-sanitary measures, exposing by bacteriological or
serological methods infected fowl and their eliminating, admi-
nistering antibiotics and other chemotherapeutical prepara-
tions (in WRAY and DAVIES, 1994). The effectiveness of
these measures is inadequate.
In the opinion of many researchers and the WHO Experts
Committee on Salmonellosis, the use of antibiotics and
chemo-preparations cannot solve this problem (World Health
Organization, 1991; WRAY and WRAY, 2000). Such treat-
ments of fowl by antibiotics and different chemo-preparations
can neither prevent nor eradicate the infection. Their constant
application results in the rise of polyresistant clones of bac-
teria. Contaminated products of poultry farming become a
source of genes of multidrug resistance for human pathogens.
For this reason, the use of antibiotics in poultry farming is now
strictly regulated in the USA and many European countries.
In this connection, development of effective vaccines,
application of competing microflora and probiotics are
recommended (WHO, 1991).
Many authors have noted the economic effectiveness
resulting from the use of vaccines for preventing salmonel-
losis in fowl in comparison with expenditures on the treat-
ment of fowl by antibiotics and chemotherapeutical prepa-
rations (WRAY and WRAY, 2000).
The existing commercial and experimental vaccines
suggested by different authors can be divided into three
basic types:
- Inactivated vaccines are represented most widely.
Their successful application for preventive effect on sal-
monellosis in fowl has been reported by many researchers
(GHOSH, 1989; GRIFFIN and BARROW, 1993; WRAY
and WRAY, 2000). The best results have been obtained by
use of emulsion (TIMMS, MARSHALL and BRESLIN,
1990; CHARLES, NAGARAJA and SIVANANDAN, 1993;
CHARLES et al., 1994; TIMMS, MARSHALL and BRES-
LIN, 1994; WRAY and WRAY, 2000) and chemical vac-
cines (BOUZOUBAA et al.,1992; TIMMS, MARSHALL
and BRESLIN, 1990; WRAY and WRAY, 2000).
- It has been established that live vaccines against salmo-
nellosis produce more pronounced immunity than inactivated
ones since they are capable to induce both humoral and cellu-
lar immunity as well as a secretory immune response. Besides
the immunity caused by live vaccines is characterized by fast
onset, intensity and duration (GUPTA and MALLICK, 1976,
1977; LASZLO, CSORIAN and PASZTI, 1985; LINDE,
FTHENAKIS and FICHTNER, 1988; COOPER et al., 1990;
BARROW, LOVELL and BERCHIERI, 1991; BARROW,
1991, 1992; LESSARD, HUTCHINGS and SPENCER, 1995;
WRAY and WRAY, 2000). In the modern world, live vaccine
manufacturing uses metabolic mutants, S. enterica ser.
Enteritidis aro-A mutants and double mutants with deletions
in genes coding for adenylate-cyclase and S.Typhimurium camp
receptor (BARROW, LOVELL and BERCHIERI, 1991;
COOPER et al., 1992; COOPER et al., 1993; GRIFFIN et
BARROW, 1993), strains with acquired resistance to antibio-
tics and lowered virulence as a result of mutations in genes
coding for ribosomal proteins and RNA polymerase (WRAY
and WRAY, 2000), and strains obtained by the insertional muta-
genesis method based on the property of transposons to trans-
pose in genome of receptive bacteria and thus disturb the func-
tioning of genes modified (VOLOZHANTSEV et al., 1997).
There are reports about developing vaccines on the basis
of recombinant Salmonella strains (BARROW, LOVELL and
BERCHIERI, 1991; WRAY and WRAY, 2000), and vaccines
on the basis of thermosensitive mutants (NAKAMURA et
al., 1994), mutants with lost genes of invasiveness (HASSAN
and CURTISS, 1994; WRAY et WRAY, 2000). 
- ZIPRIN (1997) et (ZIPRIN and KOGUT, 1997) have
developed a vaccine against salmonellosis in birds on the basis
of immune lymphokines belonging to the antiidiotypic vac-
cine type. 
As follows from the presented results a considerable expe-
rience has been widely accumulated in the field of developing
vaccines against salmonellosis in fowl and their effectiveness
and the necessity of their application have been proven.
At the same time such vaccines have shortcomings, which
limit their effectiveness, and possibilities of their wide appli-
cation, inactivated and chemical vaccines are most effective
when introduced parentally. This makes their use laborinten-
sive and impossible for chickens at their early days of age being
most sensitive to salmonellosis, causative agent. Besides vac-
cination causes stress in fowl (NAKAMURA et al., 1994).
Antiidiotypic vaccines display pronounced effective-
ness in laboratory conditions. However, high production cost
limits possibilities of their wide practical application.
In the opinion of many researchers application of live and
inactivated vaccines cannot prevent vertical transmission of sal-
monellosis, does not guarantee complete sanation of fowl from
its causative agent and its absence in poultry farming products
(Report WHO, 1991; WRAY and WRAY, 2000).
Since 1990, we performed the effectiveness of the use of
formulated vaccine from S. Typhimurium and S. Dublin sup-
pressor revertants against salmonellosis in poultry. The
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inactivated vaccine was administered orally to chickens in
their first two days, two times (109 cfu) and one time in 60
and 180 days, intramuscularly (109 cfu) in volume 0.5 cm3.
The live vaccine was administered orally during the first days
of life two times (109 cfu) and additionally, at the age of 100
days, two times (5x109 cfu). The frequency of Salmonella
detection in group immunized by the inactivated vaccine and
the live one constituted 7% and 5.6% respectively; and in
controls, 32.1% and 32.6% respectively. Despite the positive
results of the application of such preparations insufficient
effectiveness of the traditional approach in immune prevention
of salmonellosis in poultry was revealed. The main problems
consisted in the impossibility of protection from death of
already contaminated chickens in first days of life and
absence of sanitative effect in grown up birds.
Analysis of the litterature and our experience in develo-
ping and applying vaccine preparations against salmonello-
sis in poultry have served as a basis for developing prepa-
rations of a new type, Salmophages (our term), possessing
both treating and preventive action. 
• MATERIAL AND METHODS
Bacteriophages
We tested our 27 isolates of S. Enteritidis phages, 8 phages
for phage typing of S. Enteritidis from LASZLO Hungarian
collection (LASZLO, CSORIAN and PASZTI, 1985), and 10
S. Gallinarum-pullorum phages from VGNKI collection of
microorganisms.
Bacteria 
The following S. Enteritidis and S. Gallinarum strains
have been used:
- virulent epizootic strains isolated by us from poultry in
different regions of Russia in 1992-2003;
- virulent strains isolated from poultry and human from
VGNKI collection of microorganisms; the All-Russia
Salmonellosis Centre and the State Research Centre of applied
microbiology brought from Russia, Great Britain, France,
Germany, Yugoslavia, Bulgaria, Italy and Poland;
- attenuated S. Enteritidis strain 204 and R-6 phage-resis-
tant attenuated strain selected;
- for specificity of spectrum of phages, strains belonging
to several genera of enterobacteria: Citrobacter, Escherichia,
Klebsiella, Morganella, Proteus, Salmonella, Shigella,
Yersinia.
Media 
Buffered Pepton Water (CM 509), Rappoport-Vassiliadis
(RV) Enrichment Broth (CM 669), Bismuth Sulphite Agar
(CM 201), Oxoid; Agar Powder, Bacteriological (RM 026),
Nutrient Broth (M 002), Himedia.
Animals 
White mice (not purebred), 14-16 and 16-18 g body
weight. Chickens (1-43-day-old), Smena-2 cross.
Methods of investigating bacteriophages 
Isolation of phage was conducted from waste waters of
salmonellosis-unsafe poultry farms. To raise the probability
of phage detecting, the enrichment method described by
Adams was performed (ADAMS, 1959). The samples were
inoculated on beef extract broth jointly with S. Enteritidis
strain in exponential phase of growth, incubated for 18-24
hours at 37°C. The tests were filtrated (porosity of
0.22micron), then the presence of phages was searched in
microbefree filtrates by inoculation in fluid and agar media
which preliminary seeded by S. Enteritidis indicator strains.
Pure clones were obtained by consecutive cloning of mor-
phologically monotypic negative colonies. A comparative eva-
luation of morphology of negative colonies of different
phages was conducted by using one batch of cultural medium
and identical conditions of cultivation.
Electron diffraction patterns of bacteriophages were obtai-
ned with JEM 100 CX electron microscope, with accelerating
voltage of 80 kilovolts, using Tikhonenko method of negative
staining by tungstophosphoric acid (TIKHONENKO, 1968).
The bacteriophage T2 was used as model.
Activities of bacteriophages were determined as follows:
number of viable particles using Gratia methods and lytic acti-
vity using Appelmans method (ADAMS, 1959).
Salmonella Investigation 
- S. Enteritidis attenuated strain 204 was obtained by inser-
tional mutagenesis from highly virulent S. enteritidis strain
126 from human source (VOLOZHANTSEV et al., 1997);
- Tn7 transposone which is an integral part of the vector
plasmid with a ts replication DNA pVD3::Tn7 (Tc Ap Km
Sm Tp) was used for insertional mutagenesis. The plasmid
transfer to recipient S. Enteritidis 126-Rif strain was effec-
ted at the conjugation cross: E.coli JC 1553 (pVD3::Tn7) x
S. Enteritidis 126-Rif. Transconjugates S. Enteritidis 126-Rif
(pVD3::Tn7) with phenotype Rifr (determined by the rif-
mutation of strain) Tcr Apr Kmr (markers of pVD3 plasmid)
Tpr Smr (markers of Tn7 transposone) were selected.
For the selection of insertional mutants of the S. Enteritidis
126-Rif (pVD3::Tn7) bacterias grown on meat infusion at
31°C were sifted on nutrient medium which contains strep-
tomycin (50 microgram/ml) and were incubated at 43°C
which make plasmid unable to replicate autonomously. The
grown clones were subjected to the verification of the pre-
sence of non-selective markers of upper plasmid (Tc Km Ap)
and to sampling of the variants with only Tn7 markers (Sm
Tp), i.e. the clones with the insertions Tn7. 
- From inoculated mice (intraperitoneally 5x105 cfu),
Salmonella mutants giving 100% animals survival were
selected. From such clones, we selected new with the highest
immunogenecity. Then mice were immunized by cell sus-
pension of attenuated mutant (one time, subcutaneously
1x103 cfu. After 19-21 days , immunized and control animals
were infected by 10 LD50 (2x102 cfu) of virulent strain 126. 
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- Phage-resistant mutant of the strain 204 was selected
by growth with equal-volume mixture of S. Enteritidis and
S. Gallinarum-pullorum phages and control.
- Detection of Salmonella in mice and chickens was
examined as follows: shredded pieces of organs [(liver,
spleen (mice), liver, heart, kidney, intestines, ovaries
(chickens)] in ratio 1:10 were placed in buffered pepton
water, then reinoculated in Rappoport-Vassiliadis (RV)
enrichment broth, and final cultures were performed on bis-
muth Sulphite agar. Each step was obtained during 18-24
hours at 37°C, but 43°C for RV medium. Isolates were iden-
tified by biochemical and antigenic procedures. In the order
of attribution of the isolates selected to S.enterica subsp.
enterica, we determined their ability to glucose, lactose,
saccharose, mannitol, rhamnose, sorbitol, arabinose, xylose
fermentation. We also verified their ability to the hydro-
gen sulphide production, indole production, acetoin pro-
duction, revealed in Voges-Proskauer reaction, to urea
hydrolysis, to use of citrate as carbon source, as well as the
presence of lysine decarboxylase and ornithine decar-
boxylase. We performed the identification of Salmonella
isolates to serovar in the reaction of agglutination with
adsorbed monoreceptor Salmonella serums « O » and
« H », produced by Krasnodar biological plant (Russia). In
the order of differentiation of virulent strains from the atte-
nuated strain S. Enteritidis R-6, we used its ability to grown
on the mediums containing rifampicin (200 µg/ml), strep-
tomycin (200 µg/ml) and trimethoprim (200 µg/ml).  
The presence of antibodies to D group Salmonella in
chickens was determined with the help of blood-dropping
indirect agglutination reaction with pullorum erythrocytic
antigen. We considered as positive the reaction, in which the
agglutinate formation became clear in the equivoluminar
mixture of erythrocytic antigen and birds’ blood within
2minutes. The reaction was considered as negative in the case
of formation in the drop of blood with antigen of the stable
suspension of erythrocytes.
• RESULTS
From 89 poultry farm waste waters, 27 bacteriophage
were selected against indicator strains S. Enteritidis S-6. The
composition of bacteriophage populations was heterogeneous
and was represented by several types of negative colonies
(Figure1).
After cloning and 5 consecutive passages on host strain,
8 most active phages were selected (F1 to F8). From 8.4.109
to 2.0.1011 viable phage particles accumulated in their pha-
gelysates during 3-5 hours of culture in stationary conditions.
The lytic action and specifity of bacteriophages (F1 - F8) were
determined against Salmonella strains of different serovars
and some enterobacteria are represented in Table 1.
The specif icity range of phages is limited to S.
Enteritidis and S. Gallinarum-pullorum belonging to sero-
group D and considerably smaller sensitivity for strains
belonging to serogroups B (S. Typhimurium) and D (S.
Dublin). The F6 phage strain had the widest spectrum of
lytic action in relation to the main causative agents of 
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Figure 1 : Different types of negative phage colonies on the indi-
cator strain S. Enteritidis S-6.
Bacteriophage
Strain F1 F2 F3 F4 F5 F6 F7 F8
_____________________________________________________________________________________________________________
S. Enteritidis* 49/60*** 51/60 55/60 56/60 51/60 58/60 54/60 51/60
S. Enteritidis** 56/67 62/67 64/67 66/67 67/67 67/67 64/67 62/67
S. Gallinarum 24/34 30/34 28/34 30/34 26/34 31/34 29/34 28/34
S. Choleraesuis 1/15 1/15 4/15 2/15 1/15 1/15 0/15 1/15
S. Dublin 0/5 0/5 0/5 2/5 3/5 3/5 2/5 1/5
S. Typhimurium 0/5 0/5 1/5 0/5 1/5 0/5 0/5 0/5
E. coli 0/15 0/15 0/15 0/15 0/15 0/15 0/15 0/15
Y. pseudotuberculosis 0/2 0/2 0/2 0/2 0/2 0/2 0/2 0/2
Proteus sp. 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3
Morganella sp. 0/8 0/8 0/8 0/8 0/8 0/8 0/8 0/8
Klebsiella sp. 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10
Citrobacter sp. 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5
Shigella sp. 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3
____________________________________________________________________________________________________________
* from museums ** strains from poultry farms *** ratio: number of strains lysed/ number of strains tested
Table 1: Lytic spectrum and specifity range of Salmonella Enteritidis bacteriophages.
salmonellosis in poultry, S. Enteritidis and S. Gallinarum-
pullorum. The F3, F5 and F7 bacteriophages lysed a
considerable number of strains from museums and
Salmonella isolates of these serovars.
- Electron microscopic investigation of phages showed that
all of them have a binal type of symmetry, consist of equila-
teral tiny head in the form of an isometric polyhedron having
a form of an icosahedron, 50-70 nm in diameter, a long uncon-
tractable appendage with transversal streakness 105-150 nm
long, have a basal lamina and short fibrils. Phages of this type
belong to the Siphoviridae family, relate to B1 morphologi-
cal type according to classification by ACKERMANN and
DUBOV (1987).
- The most immunogenic S. Enteritidis strain 204 was
revealed by analysis of 54 insertional mutants. Immunization
of mice by 103 cfu of this attenuated strain prevented the death
of 89,3 ± 0,5% of animals challenged against the high viru-
lent strain. Its LD50 was 5x105 ± 2x104 cfu and the virulence
of the initial S. Enteritidis strain 126 constituted 18 ± 5 cfu.
The resistance markers of this strain were as follows:
rifampicin (200 µg/ml), streptomycin (200 µg/ml) and tri-
methoprim (200 µg/ml) which were stable in vitro after 10
consecutive cultures in fluid medium and in vivo after 10 pas-
sages on mice and chicken. The strain phagotyping showed
that it belongs to one of the most widespread phagotypes in
the world, phagotype IV in Wald’s scheme.
A phage-resistant mutant of the attenuated strain 204 was
obtained after 15 mixed cultures of different suspensions of
8 S. Enteritidis phages and 10 S. Gallinarum-pullorum
phages. The phage-resistant mutant, S. Enteritidis R-6, kept
all former properties (immunogenecity, resistance markers),
but the LD50 in mice was different, 8,0x106 ± 1,6x106cfu, ie,
its residual virulence declined by 15-16 fold-times.
- The study of the phage-resistant strain has demonstrated
that the tolerable dose for 3-day-old chickens constituted
4x109 cfu and the ED50 was 108 ± 4 x. 107 microbial cells. The
strains persistence time in chicken was 10-12 days, and in white
mice, 24-28 days. The attenuated strain stayed longest before
its elimination in the liver and spleen of immunized animals.
The salmophage consisted of two components: a dry live
vaccine made of the phage-resistant attenuated R-6 strain and
a bacteriophage (F6). This phage possesses the highest activity
and a wide range of lytic action among the examined phages.
- Preventive effectiveness was preliminarily studied on
a in vivo model. White mice were immunized subcuta-
neously by a preparation containing 105 cfu of the attenua-
ted strain and 5x108 F6 particles. Each group consisted of
20 animals. Other groups were either only treated by the vac-
cine either control. Finally the preparations were also admi-
nistered twice with a 3-day interval. The experimental and
control animals were contaminated at various times (1, 3, 14
days) by 5 LD50 of the virulent S. Enteritidis strain. The results
of experiments are given in Table 2.
The best protective effect was observed in the group of
mice immunized by Salmophage twice. A lower protective
effect was observed when mice were infected during periods
unable to obtain specific immunity (1 and 3 days). The intro-
duction of the preparation Salmophage was again more
effective than the use of the vaccine alone. 
- The treating and preventive effectiveness of the phage
component of the Salmophage was studied on chicken in their
first days of life. With the aim of evaluating the treating effec-
tiveness the 2-day-old chickens preliminarily were contami-
nated perorally by 5 LD50 (5x107cfu) of the S. Enteritidis viru-
lent strain and 4 hours later, they were administered perorally
5x108 phage particles. The phage treatment was repeated when
the chickens were 5-day-old. Furthermore the 5-day-old 
chickens were analogously treated by the phage, and infected
by 10 LD50 (8x108 cfu) of the S. Enteritidis virulent strain.
Experimental and control groups consisted of 24 chickens
observed during 15 days after the challenge.
Bacteriophage introduced to chickens before immuni-
zation (3 days) saved from death 100% fowl both in the expe-
rimental and control lots. 
The preliminary evaluation of effectiveness of the
Salmophage was conducted on broiler chickens of the
Smena-2 cross in the conditions of natural contamination at
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Figure 2 : Electronic microscopy  of bacteriophages S. Enteritidis
F-6.
Group Challenge Number mice** Protection 
Time* T0 T14 (%)
___________________________________________________
Vaccine 1 60 24 40.0 ± 0.35
Salmophage 1 60 43 71.7 ± 0.41
Control 1 60 0 0
___________________________________________________
Vaccine 3 60 32 53.3 ± 0.52
Salmophage 3 60 45 75.0 ± 0.28
Control 3 60 0 0
___________________________________________________
Vaccine 14 60 55 91.7 ± 0.55
Salmophage 14 60 56 93.3 ± 0.12
Control 14 60 0 0
___________________________________________________
Vaccine*** 14 60 54 90.0 ± 0.70
Salmophage*** 14 60 60 100 ± 0
Control*** 14 60 0 0
___________________________________________________
*delay between vaccination and challenge; ** Number of mice live the day
of challenge and 14 days after; *** vaccination and Salmophage given twice.
Table 2: In vivo preventive effectiveness of Salmophage in mice.
a salmonellosis-unsafe poultry farm. The experimental and
control group had 200 chickens each and kept in cages. The
salmophage was given, together with drinking water, to 3-
day-old and 6-day-old chickens (2,5x108 cfu of the vaccine
strain and 5x107 phage particles). Chickens, which died
during the experiment or were killed at the end of experiment,
were investigated for salmonellosis. 
Three chickens from experimental group died during the
whole time of experiment (43 days). Salmonella was not
detected in them. In the control group, 17 chickens died, 6
of them were infected by S. Enteritidis. At the end of the expe-
riment (term of broiler farming) 40 broilers from experimental
and control groups were examined to Salmonella carriage.
In the control group, 3 broilers were infected by S. Enteritidis.
In the group of birds, processed by salmophage, there were
no revealed Salmonella carriers. 
Finally 9 infected chickens were found during the inves-
tigation of 57 broilers in the control group. All these isolates
were identified as S. Enteritidis. Blood analysis of 150 expe-
rimental and 150 control chickens in the indirect agglutination
reaction with pullorum erythrocytic antigen revealed the pre-
sence of antibodies to group D Salmonella in 12.2% of
control chickens. The presence of antibodies to Salmonella in
broilers treated by the Salmophage was not observed.
• DISCUSSION
The aim of the present work is to try to develop a pre-
paration against salmonellosis in fowl free from shortcomings
inherent in the traditional vaccine preparations. As a result,
a preparation has been developed and constructed possessing
both treating and preventive properties.
Salmophage consists of two components: a dry live vac-
cine and a bacteriophage. As distinct from the existing pre-
parations, Salmophage besides forming an active immunity
under the influence of a vaccine strain possesses a treating
and sanitative effect due to the introduction of phage com-
ponent into the preparation.
The vaccine strain has been obtained by insertial muta-
genesis. The introduction into genome of a highly virulent S.
Enteritidis strain the transposone Tn7 besides reducing viru-
lence resulted in the emergence of stable resistance markers
in the attenuated strain. The selection from it of a phage-resis-
tant mutant brought about further considerable reduction of
virulence. Reduced virulence in phage-resistant mutants has
been described by many authors (ADAMS, 1959).
Experiments on mice have demonstrated that Salmophage
owing to the presence in it of the phage component is more
effective as a preventive agent than the traditional vaccine espe-
cially when animals were contaminated in periods insufficient
for forming an active immunity. The phage component in the
preparation can save chickens in their first days of life from death
when they are infected by high doses of the causative agent.
The preliminary study of the effectiveness of Salmophage
in the conditions of an unsafe poultry farm has shown that
the application of the preparation allows to enhance the sur-
vival of fowl and obtain Salmonella-free poultry-farm pro-
ducts. This served as a basis for conducting large-scale
experiments at poultry farms.
A valuable feature, in our opinion, of the Salmophage is
the fact that its introduction did not cause the emergence of
antibodies in birds’ blood revealed with the help of the indi-
rect agglutination reaction with pullorum erythrocytic anti-
gen. For this reason the application of the preparation does
not abolish the use of the most widespread remedy of
control salmonellosis in poultry.
• CONCLUSIONS
1. A preparation of new type against salmonellosis in fowl
has been suggested. It possesses treating and preventive pro-
perties.
2. Salmophage is more effective than the traditional
vaccine, especially when it is used in periods insufficient for
forming an active immunity.
3. The use of Salmophage does not abolish traditional dia-
gnostics with the help of the indirect agglutination reaction
with pullorum erythrocytic antigen.
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